These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18059037

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
    Chawla B, Hasan F, Seth R, Pathy S, Pattebahadur R, Sharma S, Upadhyaya A, Azad R.
    Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
    [Abstract] [Full Text] [Related]

  • 23. The expression of cyclooxygenase 2 in retinoblastoma: primary enucleated eyes and enucleation after conservative treatment.
    Souza Filho JP, Martins MC, Correa ZM, Odashiro AN, Antecka E, Coutinho AB, Macedo CR, Vianna RN, Burnier MN.
    Am J Ophthalmol; 2006 Oct; 142(4):625-31. PubMed ID: 17011855
    [Abstract] [Full Text] [Related]

  • 24. A perspective on chemoreduction and focal therapy for retinoblastoma.
    Balasubramanya R, Pushker N, Bajaj MS, Ghose S, Rani A.
    Am J Ophthalmol; 2002 Oct; 134(4):633; author reply 633-4. PubMed ID: 12383837
    [No Abstract] [Full Text] [Related]

  • 25. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma.
    Sastre X, Chantada GL, Doz F, Wilson MW, de Davila MT, Rodríguez-Galindo C, Chintagumpala M, Chévez-Barrios P, International Retinoblastoma Staging Working Group.
    Arch Pathol Lab Med; 2009 Aug; 133(8):1199-202. PubMed ID: 19653709
    [Abstract] [Full Text] [Related]

  • 26. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
    ElZomor H, Taha H, Aleieldin A, Nour R, Zaghloul MS, Fawzi M, Kamel A, Alfaar AS.
    Ophthalmic Genet; 2015 Aug; 36(3):287-9. PubMed ID: 25945688
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL, Shields JA.
    Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
    [Abstract] [Full Text] [Related]

  • 29. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [Abstract] [Full Text] [Related]

  • 30. Retinoblastoma in children older than 5 years of age.
    de Aguirre Neto JC, Antoneli CB, Ribeiro KB, Castilho MS, Novaes PE, Chojniak MM, Arias V.
    Pediatr Blood Cancer; 2007 Mar; 48(3):292-5. PubMed ID: 16847922
    [Abstract] [Full Text] [Related]

  • 31. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM, Kingston J, Hungerford JL.
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [Abstract] [Full Text] [Related]

  • 32. [Radiotherapy in the treatment of retinoblastoma: about 40 cases].
    Frikha H, Chaari N, Nasr C, Bouguila H, Chebbi A, Bhouri L, Hentati D, Kochbati L, Besbes M, Rifi H, Oubiche F, Ayed S, Maalej M.
    Cancer Radiother; 2009 Jan; 13(1):30-6. PubMed ID: 18790660
    [Abstract] [Full Text] [Related]

  • 33. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H, Khetan V, Halliday W, Héon E, Chan HS, Gallie BL.
    Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).
    Radhakrishnan V, Sharma S, Vishnubhatla S, Bakhshi S.
    Br J Ophthalmol; 2013 Jan; 97(1):52-8. PubMed ID: 23117972
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation.
    Sullivan EM, Wilson MW, Billups CA, Wu J, Merchant TE, Brennan RC, Haik BG, Shulkin B, Free TM, Given V, Rodriguez-Galindo C, Qaddoumi I.
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e335-40. PubMed ID: 24577551
    [Abstract] [Full Text] [Related]

  • 39. Vitreoretinal complications of retinoblastoma treatment.
    Tawansy KA, Samuel MA, Shammas M, Murphree AL.
    Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
    [Abstract] [Full Text] [Related]

  • 40. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.